Diagnostic Device Development Suppliers In Usa

3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling ...

We are a Boston-based company developing precision diagnostics for infectious diseases. Selux’s interdisciplinary team has expertise in microbiology, biochemistry, chemistry, engineering, software, and algorithm design and is buttressed by ...

Inspired by a friendly wager with a colleague while at a scientific conference, Horry Jones, M.D, Ph.D., successfully developed the “Metabolimeter”, the first waterless Basal Metabolism Test instrument. This significant development led to the ...

ImmunoDX, LLC (IDX) - formerly known as ImmunoDiagnostics - develops, manufactures and markets a wide range of specialty biologicals for Human T-cell Research/ Diagnostics, AIDS, HCV, HBV, TB, Cancer and Arthritis diagnostics and therapeutics ...

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine. Hemagen's mission is to offer high quality diagnostic test kits in user friendly formats. We continue to the highest quality gold standard test ...

More Diagnostics continues to introduce new controls, both with stabilized whole blood and human serum. The products are conceived in an on-site research and development department, and manufactured under stringent quality control criteria. The ...

We've manufactured over 8 million devices, three billion sensors, and developed the first FDA-cleared blood glucose meter/app for iPhone®. We've been featured by the New York Times and Fast Company, and work with some of the world's largest ...

Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved ...

Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and ...

Founded in 1983, Medica Corporation manufactures easy-to-use, easy-to-maintain, low-cost in vitro diagnostic analyzers. Continually developing new and innovative products for use in small to medium-size labs, Medica markets and sells clinical ...

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...

Since 1977, we’ve been dedicated to cardiorespiratory health solutions. Headquartered in Saint Paul, Minnesota, USA, MGC Diagnostics Corporation, develops, manufactures and markets non-invasive diagnostic systems for detecting, classifying and ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...

Protheragen-ING helps our clients achieve cost-effective improvements in their R&D productivity. Our technical and scientific teams provide reliable products and solutions to the global chemical industry, including chemical products, packaging & ...

At Phoresa, we are developing clinical diagnostics that will improve patient care, reduce physician resource strain, and save money for payers. Our disruptive diagnostic technology will allow patients to be tested and treated for infectious diseases ...

Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application ...

C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...

Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...